Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27914963)

Published in Neuropharmacology on November 30, 2016

Authors

Jesse Lea Carlin1, Shalini Jain2, Elizabeth Gizewski3, Tina C Wan3, Dilip K Tosh4, Cuiying Xiao1, John A Auchampach3, Kenneth A Jacobson4, Oksana Gavrilova2, Marc L Reitman5

Author Affiliations

1: Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, USA.
2: Mouse Metabolism Core, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, USA.
3: Department of Pharmacology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
4: Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, USA.
5: Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, USA. Electronic address: marc.reitman@nih.gov.

Articles cited by this

Further observations relating to the physiological activity of adenine compounds. J Physiol (1931) 11.29

Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol (2005) 3.88

Metabolic rate and body temperature reduction during hibernation and daily torpor. Annu Rev Physiol (2004) 3.52

Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A (2001) 2.73

Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci U S A (2001) 2.65

Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem (2000) 2.44

Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol (1998) 2.43

Effects of hypothermia for perinatal asphyxia on childhood outcomes. N Engl J Med (2014) 2.41

Constant darkness is a circadian metabolic signal in mammals. Nature (2006) 2.20

Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev (2012) 2.13

Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J Pharmacol Exp Ther (2005) 2.03

Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am J Pathol (2008) 1.93

Adenosine and kidney function. Physiol Rev (2006) 1.91

Torpor in mice is induced by both leptin-dependent and -independent mechanisms. Proc Natl Acad Sci U S A (1999) 1.84

N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors. Biochem Pharmacol (2003) 1.82

Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci U S A (1995) 1.62

(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists. J Med Chem (2005) 1.54

Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res (1997) 1.53

Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor. J Pharmacol Exp Ther (2006) 1.46

The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. Br J Pharmacol (2000) 1.42

Animal models for the study of adenosine receptor function. J Cell Physiol (2005) 1.41

AMP is an adenosine A1 receptor agonist. J Biol Chem (2012) 1.36

Season primes the brain in an arctic hibernator to facilitate entrance into torpor mediated by adenosine A(1) receptors. J Neurosci (2011) 1.34

Mast cell degranulation following adenosine A3 receptor activation in rats. Eur J Pharmacol (1996) 1.25

Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions. J Med Chem (2012) 1.23

A role of erythrocytes in adenosine monophosphate initiation of hypometabolism in mammals. J Biol Chem (2010) 1.22

Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology (Berl) (1989) 1.17

Central activation of the A1 adenosine receptor (A1AR) induces a hypothermic, torpor-like state in the rat. J Neurosci (2013) 1.17

Food restriction increases torpor and improves brown adipose tissue thermogenesis in ob/ob mice. Am J Physiol (1985) 1.16

A1 adenosine receptor agonists and their potential therapeutic applications. Expert Opin Investig Drugs (2008) 1.15

A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol Pharmacol (2001) 1.12

Torpor induction in mammals: recent discoveries fueling new ideas. Trends Endocrinol Metab (2009) 1.10

Neurological basis of AMP-dependent thermoregulation and its relevance to central and peripheral hyperthermia. J Cereb Blood Flow Metab (2012) 1.08

The circadian rhythm of body temperature. Front Biosci (Landmark Ed) (2010) 1.07

AMP does not induce torpor. Am J Physiol Regul Integr Comp Physiol (2007) 1.05

Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A1 receptors. Acta Physiol (Oxf) (2007) 1.05

The A3 adenosine receptor: history and perspectives. Pharmacol Rev (2015) 1.05

The effects of cyclic adenosine 3',5'-monophosphate and other adenine nucleotides on body temperature. J Physiol (1975) 1.02

Autonomic regulation of brown adipose tissue thermogenesis in health and disease: potential clinical applications for altering BAT thermogenesis. Front Neurosci (2014) 1.01

The pharmacology and molecular mechanisms underlying temperature regulation and torpor. Biochem Pharmacol (2008) 0.98

Molecular probes for the A2A adenosine receptor based on a pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine scaffold. Bioorg Med Chem Lett (2010) 0.97

Phase-specific central regulatory systems of hibernation in Syrian hamsters. Brain Res (2005) 0.97

Integration of body temperature into the analysis of energy expenditure in the mouse. Mol Metab (2015) 0.97

Rational design of sulfonated A3 adenosine receptor-selective nucleosides as pharmacological tools to study chronic neuropathic pain. J Med Chem (2013) 0.96

In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists. J Med Chem (2014) 0.94

Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity. J Med Chem (2012) 0.92

Effects of N6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice. Eur J Pharmacol (1993) 0.92

5'-Chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A(1) receptor agonist, alleviates neuropathic pain in mice through functional glial and microglial changes without affecting motor or cardiovascular functions. Molecules (2012) 0.91

Central adenosine receptor signaling is necessary for daily torpor in mice. Am J Physiol Regul Integr Comp Physiol (2012) 0.90

N6-cycloalkyladenosines. Potent, A1-selective adenosine agonists. J Med Chem (1985) 0.89

Circannual rhythm in body temperature, torpor, and sensitivity to A₁ adenosine receptor agonist in arctic ground squirrels. J Biol Rhythms (2013) 0.89

Altered thermoregulation via sensitization of A1 adenosine receptors in dietary-restricted rats. Psychopharmacology (Berl) (2010) 0.88

Adenosine A(3) receptors regulate heart rate, motor activity and body temperature. Acta Physiol (Oxf) (2010) 0.87

5'- Adenosine monophosphate induced hypothermia reduces early stage myocardial ischemia/reperfusion injury in a mouse model. Am J Transl Res (2011) 0.87

Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists. Neurochem Res (1991) 0.87

Characterization of the adenosine receptors mediating hypothermia in the conscious mouse. Br J Pharmacol (1994) 0.85

Biphasic effect of melanocortin agonists on metabolic rate and body temperature. Cell Metab (2014) 0.85

Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics. Br J Pharmacol (2016) 0.84

N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice. J Med Chem (2009) 0.84

Hypothermia induced by adenosine 5'-monophosphate attenuates acute lung injury induced by LPS in rats. Mediators Inflamm (2012) 0.83

N6-bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptor. J Med Chem (1989) 0.83

Adenosine--a physiological or pathophysiological agent? J Mol Med (Berl) (2013) 0.83

Mast cell adenosine receptors function: a focus on the a3 adenosine receptor and inflammation. Front Immunol (2012) 0.83

Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors. Purinergic Signal (2015) 0.83

Attenuating effect of adenosine receptor agonists on the development of behavioral sensitization induced by sporadic treatment with morphine. Pharmacol Biochem Behav (2011) 0.81

Hypothermia induced by adenosine 5'-monophosphate attenuates injury in an L-arginine-induced acute pancreatitis rat model. J Gastroenterol Hepatol (2014) 0.81

Characterization of N(6)-cyclohexyladenosine-induced hypothermia in Syrian hamsters. J Pharmacol Sci (2005) 0.81

Translating drug-induced hibernation to therapeutic hypothermia. ACS Chem Neurosci (2015) 0.80

Persistent reduction of cocaine seeking by pharmacological manipulation of adenosine A1 and A 2A receptors during extinction training in rats. Psychopharmacology (Berl) (2014) 0.79

Influences of different adenosine receptor subtypes on catalepsy in mice. Psychopharmacology (Berl) (1993) 0.79

Changes in body temperature after administration of acetylcholine, histamine, morphine, prostaglandins and related agents: II. Neurosci Biobehav Rev (1985) 0.78

Peripheral Adenosine A3 Receptor Activation Causes Regulated Hypothermia in Mice That Is Dependent on Central Histamine H1 Receptors. J Pharmacol Exp Ther (2015) 0.77

Histamine receptor signaling in energy homeostasis. Neuropharmacology (2015) 0.76

Effect of curcumin against pentylenetetrazol-induced seizure threshold in mice: possible involvement of adenosine A1 receptors. Phytother Res (2013) 0.76

Interaction of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) and opioid receptors in spinal cord nociceptive reflexes. Life Sci (2013) 0.76

5'-adenosine monophosphate-induced hypothermia attenuates brain ischemia/reperfusion injury in a rat model by inhibiting the inflammatory response. Mediators Inflamm (2015) 0.76

Future approaches to therapeutic hypothermia: a symposium report. Temperature (Austin) (2015) 0.76